Stanford student Xiangnong (George) Wang worked with Lex Machina and used our data to conduct an empirical investigation into current trends in generic drug litigation from January 1, 2006 to August 1, 2011. He studied the determinants of settlement and other outcomes in over 1,000 ANDA cases. He concluded that factors such as declaratory judgment, the size of a brand pharma company, the level of patent protection and remaining exclusivity for a patent may be significant factors.

Download Thesis

Download Tables & Figures